SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-004137
Filing Date
2019-03-28
Accepted
2019-03-28 17:25:38
Documents
70
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1007835
2 ex21-1.htm EX-21.1 4696
3 ex23-1.htm EX-23.1 4718
4 ex31-1.htm EX-31.1 11696
5 ex31-2.htm EX-31.2 11953
6 ex32-1.htm EX-32.1 8241
  Complete submission text file 0001493152-19-004137.txt   4131236

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE pcsa-20181231.xml EX-101.INS 477975
8 XBRL SCHEMA FILE pcsa-20181231.xsd EX-101.SCH 49863
9 XBRL CALCULATION FILE pcsa-20181231_cal.xml EX-101.CAL 62739
10 XBRL DEFINITION FILE pcsa-20181231_def.xml EX-101.DEF 191573
11 XBRL LABEL FILE pcsa-20181231_lab.xml EX-101.LAB 370837
12 XBRL PRESENTATION FILE pcsa-20181231_pre.xml EX-101.PRE 295510
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-184948 | Film No.: 19713031
SIC: 2834 Pharmaceutical Preparations